share_log
Breakings ·  Aug 26 22:29
PTC Therapeutics Inc : UBS Resumes Coverage With Buy Vs Neutral Rating; Target Price $47
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment